N-(3-Chloro-2-methylphenyl)-2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

Catalog No. :
ACOMIR981
CAS No. :
482639-89-4
Molecular Formula :
C18H18ClN5OS
Molecular Weight :
387.90

IUPAC Name:N-(3-chloro-2-methylphenyl)-2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

N-(3-Chloro-2-methylphenyl)-2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Chloro-2-methylphenyl)-2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
IUPAC NameN-(3-chloro-2-methylphenyl)-2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
Molecular FormulaC18H18ClN5OS
Molecular Weight387.90
SMILESO=C(NC1=CC=CC(Cl)=C1C)CSC2=NN=C(C3=CC=NC=C3)N2CC
InChI KeyKCNOZHQBYKQAGZ-UHFFFAOYSA-N
SynonymN-(3-CHLORO-2-METHYLPHENYL)-2-([4-ETHYL-5-(4-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)ACETAMIDE;N-(3-chloro-2-methylphenyl)-2-{[4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide;SALOR-INT L411248-1EA;Acetamide, N-(3-chloro-2-methylphenyl)-2-[[4-ethyl-5-(4-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-
CAS No.482639-89-4

Synthetic Route by SureRoute

1. ACOMIR981 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  4. Then
  5. ACOMIR981 route product structure diagram
    ACOMIR981482639-89-4
Inquiry

2. ACOMIR981 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACZAEU048 route compound structure diagram
    ACZAEU04899585-94-1
  4. Then
  5. ACOMIR981 route product structure diagram
    ACOMIR981482639-89-4
Inquiry

Comments (0)